BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30624081)

  • 1. Population-based validation of the National Comprehensive Cancer Network recommendations for baseline imaging for bladder cancer: a case for routine baseline bone scan?
    Abdel-Rahman O
    J Comp Eff Res; 2019 Feb; 8(3):157-163. PubMed ID: 30624081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
    Abdel-Rahman O
    Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
    Abdel-Rahman O
    Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based assessment of the National Comprehensive Cancer Network recommendations for baseline imaging of rectal cancer.
    Abdel-Rahman O; Cheung WY
    J Comp Eff Res; 2019 Oct; 8(14):1167-1172. PubMed ID: 31638428
    [No Abstract]   [Full Text] [Related]  

  • 5. Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma.
    Abdel-Rahman O; Cheung WY
    Med Oncol; 2019 Feb; 36(3):26. PubMed ID: 30707324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?
    Abdel-Rahman O
    J Comp Eff Res; 2019 Jun; 8(8):569-575. PubMed ID: 31116030
    [No Abstract]   [Full Text] [Related]  

  • 7. North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients.
    Preisser F; Mazzone E; Nazzani S; Marchioni M; Bandini M; Tian Z; Saad F; Soulières D; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Br J Cancer; 2018 Dec; 119(12):1552-1556. PubMed ID: 30425350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer.
    Furrer MA; Grueter T; Bosshard P; Vartolomei MD; Kiss B; Thalmann GN; Roth B
    Eur Urol Focus; 2021 Sep; 7(5):1052-1060. PubMed ID: 33060038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metastases in muscle-invasive bladder cancer.
    Taher AN; Kotb MH
    J Egypt Natl Canc Inst; 2006 Sep; 18(3):203-8. PubMed ID: 17671529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer.
    Erturan S; Yaman M; Aydin G; Uzel I; Müsellim B; Kaynak K
    Chest; 2005 Feb; 127(2):449-54. PubMed ID: 15705981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of excretory urography, ultrasonography, computerized tomography, and liver and bone scan in the staging of bilharzial bladder cancer in Saudi Arabia.
    Hanash KA; Bissada NK; Abla A; Esmail D; Dowling A
    Cancer; 1984 Jul; 54(1):172-6. PubMed ID: 6232995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients.
    Ma MW; Gao XS; Lyu F; Gu XB; Yin H; Li HZ; Li XY; Qi X; Bai Y; Chen JY
    World J Urol; 2021 Jun; 39(6):1815-1823. PubMed ID: 32691147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer local staging: multiparametric MRI performance following transurethral resection.
    van der Pol CB; Shinagare AB; Tirumani SH; Preston MA; Vangel MG; Silverman SG
    Abdom Radiol (NY); 2018 Sep; 43(9):2412-2423. PubMed ID: 29313114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting extrathoracic metastases in patients with non-small cell lung cancer: Is routine scanning necessary?
    Metintas M; Ak G; Akcayir IA; Metintas S; Erginel S; Alatas F; Yildirim H; Kurt E; Ozkan R
    Lung Cancer; 2007 Oct; 58(1):59-67. PubMed ID: 17566597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder cancer: the value of routine bone scintigraphy.
    Davey P; Merrick MV; Duncan W; Redpath AT
    Clin Radiol; 1985 Jan; 36(1):77-9. PubMed ID: 4064487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer.
    Braendengen M; Winderen M; Fosså SD
    Br J Urol; 1996 Jan; 77(1):36-40. PubMed ID: 8653315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastatic bone disease. Strategies for imaging].
    Scutellari PN; Antinolfi G; Galeotti R; Giganti M
    Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream Studies Following the Use of Bone Scan in the Staging of Muscle-invasive Bladder Cancer.
    Maganty A; Turner RM; Yabes JG; Davies BJ; Heron DE; Jacobs BL
    Urology; 2019 Jul; 129():74-78. PubMed ID: 31005656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.